Keyphrases
Autoantibodies
100%
Plasma Cells
100%
Bortezomib
100%
Experimental Autoimmune Myasthenia Gravis
100%
Proteasome Inhibition
100%
Titer
28%
Acetylcholine Receptor Antibody
28%
Acetylcholine Receptor (AChR)
28%
Autoimmune Disease
14%
Induced Apoptosis
14%
Immunization
14%
Clinical Conditions
14%
Protease Inhibitors
14%
T Cells
14%
Skeletal muscle
14%
Myasthenia Gravis
14%
Immunosuppressive Therapy
14%
Bone Marrow
14%
Saline Control
14%
Lewis Rats
14%
Bone Marrow Cells
14%
B Cells
14%
Neuromuscular Transmission
14%
First Week
14%
Targeted Treatment
14%
Saline Injection
14%
Therapeutic Use
14%
Immunology
14%
Long-lived Plasma Cells
14%
Myasthenic
14%
Lupus-like Disease
14%
Torpedo
14%
Ultrastructural Damage
14%
Synaptic Membrane
14%
INIS
inhibition
100%
plasma cells
100%
diseases
75%
receptors
75%
acetylcholine
75%
rats
50%
injection
50%
symptoms
50%
damage
25%
control
25%
animals
25%
muscles
25%
mice
25%
apoptosis
25%
membranes
25%
transmission
25%
bone marrow
25%
lupus
25%
immunology
25%
bone marrow cells
25%
therapeutic uses
25%
Immunology and Microbiology
Proteasome
100%
Autoantibodies
100%
Experimental Autoimmune Myasthenia Gravis
100%
Immunoglobulin Producing Cell
100%
Titer
50%
Skeletal Muscle
25%
Immunosuppressant
25%
Immunosuppressive Drug
25%
T Cell
25%
Autoimmune Disease
25%
B Cell
25%
Lewis Rat
25%
Bone Marrow Cell
25%
Neuromuscular Transmission
25%
Myasthenia gravis
25%
Postsynaptic Membrane
25%
Drug-Induced Lupus Erythematosus
25%